Search Results - Gregor Hoermann
- Showing 1 - 20 results of 30
- Go to Next Page
-
1
-
2
-
3
-
4
Testosterone Deficiency Is a Risk Factor for Severe COVID-19 by Lukas Lanser, Francesco Robert Burkert, Lis Thommes, Alexander Egger, Gregor Hoermann, Gregor Hoermann, Susanne Kaser, Germar Michael Pinggera, Markus Anliker, Andrea Griesmacher, Günter Weiss, Rosa Bellmann-Weiler
Published in Frontiers in Endocrinology (2021-06-01)Get full text
Article -
5
-
6
P689: CLASSIFICATION OF MDS AND AML BASED SOLELY ON GENETICS OMITTING BLAST COUNTING – A WAY TO RESOLVE THE DISCREPANCIES BETWEEN CLASSIFICATIONS ACCORDING TO WHO AND ICC? by Claudia Haferlach, Sandra Huber, Constance Baer, Stephan Hutter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Gregor Hoermann
Published in HemaSphere (2023-08-01)Get full text
Article -
7
-
8
P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED? by Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann
Published in HemaSphere (2023-08-01)Get full text
Article -
9
Classical meets malignant hematology: a case of acquired εγδβ-thalassemia in clonal hematopoiesis by Armin P. Piehler, Marietta Truger, Jan-Hendrik Kozik, Sandra Weissmann, Martin Schwonzen, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Gregor Hoermann, Claudia Haferlach
Published in Haematologica (2024-03-01)Get full text
Article -
10
P708: HIGH MUTATIONAL CONCORDANCE IN PAIRED BONE MARROW AND PERIPHERAL BLOOD SAMPLES IN PATIENTS WITH CONFIRMED OR SUSPECTED MYELODYSPLASTIC NEOPLASM by Natalie Wossidlo, Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann, Isolde Summerer, Henning Ruge, Constance Baer, Wolfgang Kern, Claudia Haferlach
Published in HemaSphere (2023-08-01)Get full text
Article -
11
Borderline and weakly positive antibody levels against the S-protein of SARS-CoV-2 exhibit limited agreement with virus neutralization titres by Alexander E. Egger, Christian Irsara, Barbara Holzer, Christoph Winkler, Rosa Bellmann-Weiler, Günter Weiss, Boris Hartmann, Wolfgang Prokop, Gregor Hoermann, Andrea Griesmacher, Markus Anliker
Published in Journal of Clinical Virology Plus (2022-02-01)Get full text
Article -
12
Preclinical human models and emerging therapeutics for advanced systemic mastocytosis by Michel Arock, Ghaith Wedeh, Gregor Hoermann, Siham Bibi, Cem Akin, Barbara Peter, Karoline V. Gleixner, Karin Hartmann, Joseph H. Butterfield, Dean D. Metcalfe, Peter Valent
Published in Haematologica (2018-11-01)Get full text
Article -
13
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H by Peter Valent, Katharina Blatt, Gregor Eisenwort, Harald Herrmann, Sabine Cerny-Reiterer, Renate Thalhammer, Leonhard Müllauer, Gregor Hoermann, Irina Sadovnik, Ilse Schwarzinger, Wolfgang R. Sperr, Christine Mannhalter, Hans-Peter Horny
Published in Leukemia Research Reports (2014-01-01)Get full text
Article -
14
Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis by Georg Greiner, Michael Gurbisz, Franz Ratzinger, Nadine Witzeneder, Svenja Verena Class, Gregor Eisenwort, Ingrid Simonitsch-Klupp, Harald Esterbauer, Matthias Mayerhofer, Leonhard Müllauer, Wolfgang R. Sperr, Peter Valent, Gregor Hoermann
Published in Haematologica (2020-02-01)Get full text
Article -
15
The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils. by Katharina Blatt, Harald Herrmann, Irina Mirkina, Emir Hadzijusufovic, Barbara Peter, Sabine Strommer, Gregor Hoermann, Matthias Mayerhofer, Konrad Hoetzenecker, Walter Klepetko, Viviane Ghanim, Katharina Marth, Thorsten Füreder, Volker Wacheck, Rudolf Valenta, Peter Valent
Published in PLoS ONE (2012-01-01)Get full text
Article -
16
CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance by Eva Maria Putz, Dagmar Gotthardt, Gregor Hoermann, Agnes Csiszar, Silvia Wirth, Angelika Berger, Elisabeth Straka, Doris Rigler, Barbara Wallner, Amanda M. Jamieson, Winfried F. Pickl, Eva Maria Zebedin-Brandl, Mathias Müller, Thomas Decker, Veronika Sexl
Published in Cell Reports (2013-08-01)Get full text
Article -
17
One-Year Follow-Up of COVID-19 Patients Indicates Substantial Assay-Dependent Differences in the Kinetics of SARS-CoV-2 Antibodies by Alexander E. Egger, Sabina Sahanic, Andreas Gleiss, Franz Ratzinger, Barbara Holzer, Christian Irsara, Nikolaus Binder, Christoph Winkler, Christoph J. Binder, Wilfried Posch, Lorin Loacker, Boris Hartmann, Markus Anliker, Guenter Weiss, Thomas Sonnweber, Ivan Tancevski, Andrea Griesmacher, Judith Löffler-Ragg, Gregor Hoermann
Published in Microbiology Spectrum (2022-12-01)Get full text
Article -
18
Pulmonary recovery from COVID-19 in patients with metabolic diseases: a longitudinal prospective cohort study by Thomas Sonnweber, Philipp Grubwieser, Alex Pizzini, Anna Boehm, Sabina Sahanic, Anna Luger, Christoph Schwabl, Gerlig Widmann, Alexander Egger, Gregor Hoermann, Ewald Wöll, Bernhard Puchner, Susanne Kaser, Igor Theurl, Manfred Nairz, Piotr Tymoszuk, Günter Weiss, Michael Joannidis, Judith Löffler-Ragg, Ivan Tancevski
Published in Scientific Reports (2023-02-01)Get full text
Article -
19
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia by Karoline V. Gleixner, Mathias Schneeweiss, Gregor Eisenwort, Daniela Berger, Harald Herrmann, Katharina Blatt, Georg Greiner, Konstantin Byrgazov, Gregor Hoermann, Marina Konopleva, Islam Waliul, Abbarna A. Cumaraswamy, Patrick T. Gunning, Hiroshi Maeda, Richard Moriggl, Michael Deininger, Thomas Lion, Michael Andreeff, Peter Valent
Published in Haematologica (2017-09-01)Get full text
Article -
20
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML by Mathias Schneeweiss-Gleixner, Konstantin Byrgazov, Gabriele Stefanzl, Daniela Berger, Gregor Eisenwort, Chantal Blanche Lucini, Susanne Herndlhofer, Sandra Preuner, Klara Obrova, Petra Pusic, Nadine Witzeneder, Georg Greiner, Gregor Hoermann, Wolfgang R. Sperr, Thomas Lion, Michael Deininger, Peter Valent, Karoline V. Gleixner
Published in EBioMedicine (2019-12-01)Get full text
Article
